Pulmonary Hypertension Registry Switzerland

Pulmonary Hypertension Clinical Trial

Official title:

Swiss PH Registry - Cohort of Swiss PH Patients

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05610631
• Other study ID #: Swiss PH Registry
• Status: Recruiting
• Start date: June 1, 2017
• Est. completion date: December 2027

Study information

• Verified date: November 2022
• Source: University of Zurich
• Contact: Silvia Ulrich, Prof. Dr.
• Phone: +41442552220
• Email: silvia.ulrich[@]usz.ch
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Registry Data from PH-patients in Switzerland, who have given consent to records for research purposes.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1000
• Est. completion date: December 2027
• Est. primary completion date: December 2027
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients with PH

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Hypertension
• Hypertension, Pulmonary
• Pulmonary Hypertension

Locations

Country	Name	City	State
Switzerland	Respiratory Clinic, University Hospital of Zurich	Zurich

Sponsors (2)

Lead Sponsor	Collaborator
University of Zurich	Actelion

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	6-minute walking distance	6-minute walking distance	within the study duration e.g. up to 10 years
Secondary	New York Heart Association functional class	New York Heart Association functional class	within the study duration e.g. up to 10 years
Secondary	NTproBNP	NTproBNP	within the study duration e.g. up to 10 years
Secondary	Survival	time to death analysis	within the study duration e.g. up to 10 years
Secondary	Medication	escalation of clinical therapy	within the study duration e.g. up to 10 years